MedTrace Logo

Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear Imaging

NCT00185081 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2016-04-07

No results posted yet for this study

Summary

The purpose of this study is to test the safety of the peptide and antibody and at the same time evaluate the tumor imaging of a two step antibody technique in nuclear imaging.

Conditions

  • Colonic Neoplasms

Interventions

DRUG

Indium labeled IMP-205xm734

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Wim Oyen, MD PhD · Radboud University Medical Centre Nijmegen

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00185081 on ClinicalTrials.gov